229 related articles for article (PubMed ID: 11900154)
1. Illegal drug use and public policy.
Grossman M; Chaloupka FJ; Shim K
Health Aff (Millwood); 2002; 21(2):134-45. PubMed ID: 11900154
[TBL] [Abstract][Full Text] [Related]
2. Coke and smack at the drugstore: harm reductive drug legalization: an alternative to a criminalization society.
Mamber N
Cornell J Law Public Policy; 2006; 15(3):619-64. PubMed ID: 17593583
[No Abstract] [Full Text] [Related]
3. The long and winding road to cannabis legalization.
Van Ours JC
Addiction; 2012 May; 107(5):872-3. PubMed ID: 22471565
[No Abstract] [Full Text] [Related]
4. The effects of macro-level interventions on addictive behavior.
Pacula RL; Chaloupka FJ
Subst Use Misuse; 2001 Dec; 36(13):1901-22. PubMed ID: 11795584
[TBL] [Abstract][Full Text] [Related]
5. Individual behaviours and substance use: the role of price.
Grossman M
Adv Health Econ Health Serv Res; 2005; 16():15-39. PubMed ID: 17867233
[TBL] [Abstract][Full Text] [Related]
6. Design considerations for legalizing cannabis: lessons inspired by analysis of California's Proposition 19.
Caulkins JP; Kilmer B; MacCoun RJ; Pacula RL; Reuter P
Addiction; 2012 May; 107(5):865-71. PubMed ID: 21985069
[TBL] [Abstract][Full Text] [Related]
7. Legalizing drugs: lessons from (and about) economics.
Warner KE
Milbank Q; 1991; 69(4):641-61. PubMed ID: 1806805
[TBL] [Abstract][Full Text] [Related]
8. An economic analysis of different cannabis decriminalization scenarios.
Ogrodnik M; Kopp P; Bongaerts X; Tecco JM
Psychiatr Danub; 2015 Sep; 27 Suppl 1():S309-14. PubMed ID: 26417786
[TBL] [Abstract][Full Text] [Related]
9. Shifting from an illegal-drug policy to a psychoactive substance policy.
van der Linde F
Soz Praventivmed; 2006; 51(3):128-9. PubMed ID: 17191533
[No Abstract] [Full Text] [Related]
10. A social cost perspective in the wake of the Portuguese strategy for the fight against drugs.
Gonçalves R; Lourenço A; Silva SN
Int J Drug Policy; 2015 Feb; 26(2):199-209. PubMed ID: 25265899
[TBL] [Abstract][Full Text] [Related]
11. Practical experience with legalized cannabis.
Gieringer D
Addiction; 2012 May; 107(5):875-6. PubMed ID: 22471567
[No Abstract] [Full Text] [Related]
12. Diminishing returns and great potential: a comment on Pollack's & Reuter's review on tougher drug enforcement and prices.
Caulkins JP
Addiction; 2014 Dec; 109(12):1967-8. PubMed ID: 25384929
[No Abstract] [Full Text] [Related]
13. Does tougher enforcement make drugs more expensive?
Pollack HA; Reuter P
Addiction; 2014 Dec; 109(12):1959-66. PubMed ID: 24621331
[TBL] [Abstract][Full Text] [Related]
14. The economics of tobacco regulation.
Gruber J
Health Aff (Millwood); 2002; 21(2):146-62. PubMed ID: 11900155
[TBL] [Abstract][Full Text] [Related]
15. Additional considerations.
Nadelmann E; Gutwillig S; Davies J
Addiction; 2012 May; 107(5):873-5. PubMed ID: 22471566
[No Abstract] [Full Text] [Related]
16. A quagmire for our time: the war on drugs.
Schrag P
J Public Health Policy; 2002; 23(3):286-98. PubMed ID: 12325286
[No Abstract] [Full Text] [Related]
17. The analysis of policy: understanding the process of policy development.
Ryder D
Addiction; 1996 Sep; 91(9):1265-70. PubMed ID: 8854357
[TBL] [Abstract][Full Text] [Related]
18. Some critical issues in cannabis policy reform.
Uchtenhagen A
Addiction; 2014 Mar; 109(3):356-8. PubMed ID: 24524316
[No Abstract] [Full Text] [Related]
19. Legalization of drugs of abuse and the pediatrician.
Schwartz RH
Am J Dis Child; 1991 Oct; 145(10):1153-8. PubMed ID: 1928008
[TBL] [Abstract][Full Text] [Related]
20. Redefining the goals of national drug policy: recommendations from a working group.
Reuter P; Caulkins JP
Am J Public Health; 1995 Aug; 85(8 Pt 1):1059-63. PubMed ID: 7625496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
